Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/yingli-pharma-announces-successful-end-of-phase-2-meeting-with-fda-and-clearance-of-global-multi-center-phase-3-registration-study-design-of-linperlisib-for-the-treatment-of-relapsed-andor-refractory-peripheral-t-cell-lymphoma-302416397.html
11 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/yingli-pharma-presents-a-pivotal-phase-2-study-data-evaluating-linperlisib-in-relapsed-or-refractory-peripheral-t-cell-lymphoma-in-an-oral-session-at-the-american-society-of-hematology-2023-annual-meeting-302010879.html
03 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/yingli-pharma-announces-first-patient-dosed-in-phase-2-trial-of-linperlisib-for-peripheral-t-cell-lymphoma-301617369.html
20 Jan 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/01/20/2370411/0/en/Yingli-Pharma-and-MD-Anderson-Initiate-Strategic-Collaboration-to-Advance-Development-of-Multiple-Oncology-Programs.html
10 Jun 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/yingli-pharma-announces-a-presentation-on-the-phase-2-clinical-trial-of-linperlisib-a-pi3k-selective-inhibitor-in-relapsed-or-refractory-follicular-lymphoma-at-the-european-hematology-association-2021-congress-301310715.html
10 Jun 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/yingli-pharma-announces-a-presentation-on-the-phase-2-clinical-trial-of-linperlisib-a-pi3k-selective-inhibitor-in-relapsed-or-refractory-follicular-lymphoma-at-the-european-hematology-association-2021-congress-301310715.html
ABOUT THIS PAGE